Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern

Why does it matter? Because OCD, addiction, and binge eating disorder share one broken circuit — and a surgeon is learning to read it in real time

Dr. Casey Halpern operates inside the nucleus accumbens, a subcortical gate that drives reward-seeking behavior. When it misfires, it compels humans to pursue rewards despite punishment, risk, and conscious awareness — the biological root of compulsion at its most severe. His work suggests three of the largest public health crises share one malfunctioning node.

• A perturbed nucleus accumbens drives compulsive reward-seeking across OCD, addiction, and binge eating disorder — one circuit, three diagnoses • Treatment-resistant patients binge under one-way-mirror surveillance, fully knowing they're being filmed; the circuit ignores what the mind knows • Individual "craving cells" fire in a detectable pattern before a compulsive episode — a closed-loop device can catch that signal and stimulate before the binge begins • DBS achieves roughly a 50% responder rate for OCD, and even those patients still have symptomatic OCD — the surgical ceiling is real and sobering

OCD, addiction, and binge eating disorder are three names for one broken gate

The nucleus accumbens gates reward-seeking. When it's perturbed, Halpern explains, it compels the pursuit of reward despite punishment — a rat crosses a shock pad to reach food; an OCD patient checks the door lock until 3 a.m. knowing it's already secured; a drug addict pays a dealer despite lethal risk. Halpern calls this "the urge despite the risk" — the common denominator across OCD, addiction, and eating disorders.

These aren't separate research problems requiring separate solutions. They are one circuit misfiring, and the public health math is stark: addiction, compulsive eating, and OCD together touch tens of millions of Americans. A single neuromodulation target could theoretically address all three. Stop framing them as unrelated psychiatric categories and the treatment landscape shifts entirely.

Severe compulsion survives full awareness — patients binge on camera knowing exactly what is happening

Halpern's patients binge in a monitored lab, observed through a one-way mirror, wearing eye trackers, with synchronized video running. They know exactly what's happening. They binge anyway. "In these really refractory patients," he says, "this is the disease. Despite the awareness, they can't control themselves."

Everyone who reaches a neurosurgeon has already cycled through CBT, medications, and behavioral management. Awareness has been fully deployed and wasn't sufficient. For the most severe cases, more self-monitoring tools won't shift the outcome — the circuit overrides what the mind knows. What's missing is circuit-level control, and that's precisely what Halpern is trying to restore.

Individual neurons fire before a compulsive episode — a device listening for them could interrupt the binge before it starts

The Parkinson's parallel is exact: tremor cells fire at the same frequency as a shaking hand; stimulate that region, the tremor dissolves. Halpern applied the same logic to craving. In a single OCD case study, his team identified cells corresponding to obsessions — proof that disease-specific neural signals can be isolated in the operating room.

For binge eating, the protocol is precise. A psychiatrist administers a validated "mood provocation," inducing the emotional state that precedes each patient's binge, while eye trackers synchronize gaze to brain recordings. The goal is to isolate the craving cell signature in the seconds before the first bite — then build a closed-loop device that listens for it continuously.

The current DBS ceiling clarifies why this matters: roughly 50% of OCD patients respond to surgery, and those responders still have symptomatic OCD. Stimulation timed to an actual craving signal, rather than delivered continuously regardless of symptom state, is the pathway to moving both numbers.

Gambling addictions dissolved in Parkinson's patients — the most consequential psychiatric neuromodulation targets were found by accident

Nobody designed the first psychiatric DBS targets. Surgeons placing electrodes in motor circuits to treat Parkinson's tremor found patients reporting unexpected changes — mood lifting, gambling compulsions fading — while the declared goal was only stopping a shaking hand. The electrodes happened to sit where motor and limbic circuits overlap, and stimulation modulated emotion whether or not anyone intended it.

"Often these side effects could be therapeutic. That's how we discovered ways to use deep brain stimulation not just for movement disorders but for psychiatric comorbidities," Halpern explains.

Parkinson's DBS cohorts are an underused data source. Mining them systematically for changes in psychiatric comorbidities could surface new targets without designing new invasive trials from scratch — a faster and cheaper path than the field is currently taking.

Focused ultrasound already ablates a 3–4mm brain region without a scalpel — the missing piece isn't the technology, it's the coordinates

MRI-guided focused ultrasound delivers a precise ablation to a 3–4mm target with no incision, no electrode, no craniotomy. Halpern performs it routinely for tremor patients. "There's no incision. I don't have to place an electrode into the brain. It's fabulously effective for these patients."

For psychiatric conditions, the hardware bottleneck is solved. The scientific bottleneck is knowing where to aim. "The problem is we don't know where to do the ablation."

Every craving cell mapped, every obsession signal recorded with an invasive electrode — this is how the coordinates get built. "We have to get in the brain before we get out of it. If we understand what these signals look like, we'll know what those non-invasive signals are." Funding invasive psychiatric neuroscience today is directly accelerating a non-surgical treatment pathway.

The obsessiveness that makes surgeons meticulous and CEOs relentless is OCD with functioning brakes

Halpern is candid about his own wiring: "I'm really obsessive about safety and compulsive about my surgical procedures." He places surgeons, scientists, and CEOs on the same spectrum as his patients — and argues the comparison deserves serious consideration rather than a knowing laugh.

His frame: "Perhaps if it can be controlled, it's an asset. But if it goes awry and is uncontrollable, then it becomes obsessive-compulsive disorder."

The circuit is identical across the spectrum. The question isn't whether high-intensity checking and perfectionist loops exist in you — it's whether you control the behavior or the behavior controls you. That distinction separates a professional asset from a clinical diagnosis.

The surgery is temporary; the map it draws is permanent

Two hundred thousand DBS surgeries have been performed worldwide — ever. Fifty million Americans have the conditions Halpern is trying to treat. Scale requires something beyond a scalpel. What the invasive work provides isn't only treatment for the rare, severe patient — it's coordinates. Craving cell signatures and obsession biomarkers become the parameters that will eventually tell a focused ultrasound system exactly where to fire, without opening anything.

The operating room is a laboratory. Everything learned inside it is an investment in never having to go back in.

---

Topics: deep brain stimulation, OCD, compulsive behavior, nucleus accumbens, binge eating disorder, addiction, focused ultrasound, TMS, neuromodulation, impulsivity, craving, closed-loop neurostimulation, Parkinson's disease, psychiatric neurosurgery